PropertyValue
?:abstract
  • Development of novel antiviral molecules from the beginning costs an average of $350 million to $2 billion per drug, and the journey from the laboratory ... »more»
is ?:annotates of
?:creator
?:doi
  • 10.3390/jcm9113777
?:doi
?:journal
  • J_Clin_Med
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/5b3244649bc027cedad5c752e6377229038cbee5.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7700377.xml.json
?:pmcid
?:pmid
?:pmid
  • 33238464.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Drug Repurposing Approaches to Combating Viral Infections
?:type
?:year
  • 2020-11-23

Metadata

Anon_0  
expand all